Skip to main content

Table 3 Comparisons between patients with or without a K-ras or APC mutation and hMLH1 expression.

From: Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study

 

Genetic aberration

 

APC a

K-ras b

hMLH1 expression

 

No mutation

(truncation)

Mutation

(truncation)

No mutation

(codon 12/13)

Mutation

(codon 12/13)

Present

Absent

Number of patients (%)

411

(63)

245

(37)

421

(64)

235

(36)

598

(91)

58

(9)

Age at diagnosis (yr, mean (SD))

68.2

(4.3)

67.5

(4.2)

67.7

(4.3)

68.3

(4.3)

67.9

(4.2)

68.7

(4.7)

   P-value

0.07

0.08

0.18

Sex (% male)

54

 

58

56

 

55

 

57

 

45

 

   P-value

0.45

0.84

0.08

Family history of colorectal cancer (% yes)

10

 

9

11

 

7

 

10

 

9

 

   P-value

0.89

0.07

0.79

Tumour sub-localisationc

            

   Proximal colon

151

(69%)

67

(31%)

141

(65%)

77

(35%)

169

(78%)

49

(12%)

   Distal colon

138

(68%)

66

(32%)

144

(71%)

60

(29%)

199

(98%)

5

(2%)

   Rectosigmoid

34

(47%)

39

(53%)

44

(60%)

29

(40%)

73

(100%)

0

(0%)

   Rectum

83

(55%)

67

(45%)

85

(57%)

65

(43%)

146

(97%)

4

(3%)

   P-value

<0.001

0.05

<0.001

Dukes' stagec

            

   A

94

(60%)

63

(40%)

103

(66%)

54

(34%)

142

(90%)

15

(10%)

   B

147

(67%)

73

(33%)

142

(65%)

78

(35%)

192

(87%)

28

(13%)

   C

97

(60%)

64

(40%)

107

(66%)

54

(34%)

151

(94%)

10

(6%)

   D

39

(54%)

33

(46%)

40

(56%)

32

(44%)

69

(96%)

3

(4%)

   P-value

0.21

0.42

0.07

Differentiationc

            

   Good

35

(56%)

28

(44%)

40

(63%)

23

(37%)

59

(94%)

4

(6%)

   Moderate

250

(62%)

156

(38%)

258

(64%)

148

(34%)

380

(94%)

26

(6%)

   Poor

66

(69%)

30

(31%)

68

(71%)

28

(29%)

82

(85%)

14

(15%)

   Undifferentiated

6

(86%)

1

(14%)

5

(71%)

2

(29%)

4

(57%)

3

(43%)

   P-value

0.20

0.57

<0.001

  1. a APC mutations: only mutations resulting in a stop codon.
  2. b K-ras mutations: only activating mutations in codon 12 or 13.
  3. c Tumour sublocalisation, Dukes's stage and differentiation gave rise to missing values.